James Mullen
Director/Board Member at THERMO FISHER SCIENTIFIC
Net worth: 2 M $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Stuart R. Grant | M | 69 |
DPx Holdings BV
DPx Holdings BV Drugstore ChainsRetail Trade DPx Holdings BV provides pharmaceutical services, fine chemicals and proprietary products and technologies. It operates business through three business unites which include Patheon, DSM Fine Chemicals and Banner Life Sciences. Patheon consists of pharmaceutical services, which include commercial manufacturing capabilities, pharmaceutical development services, as well as the biologics and biosolutions businesses; DSM Fine Chemicals includes active pharmaceutical ingredients services as well as the ES/IM business offer is primarily comprised of agricultural and crop protection chemicals and specialty intermediates; and Banner Life Sciences serves the needs of the proprietary products business and will now include additional brands from DPP. The company has offices in Australia, Europe, Latin America and North America. DPx Holdings was founded in March 2014 and is headquartered in Framingham, MA. | 3 years |
Marc Casper | M | 56 | 23 years | |
John Cox | M | 61 |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA.
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 20 years |
Rebecca M. Holland New | M | 49 |
DPx Holdings BV
DPx Holdings BV Drugstore ChainsRetail Trade DPx Holdings BV provides pharmaceutical services, fine chemicals and proprietary products and technologies. It operates business through three business unites which include Patheon, DSM Fine Chemicals and Banner Life Sciences. Patheon consists of pharmaceutical services, which include commercial manufacturing capabilities, pharmaceutical development services, as well as the biologics and biosolutions businesses; DSM Fine Chemicals includes active pharmaceutical ingredients services as well as the ES/IM business offer is primarily comprised of agricultural and crop protection chemicals and specialty intermediates; and Banner Life Sciences serves the needs of the proprietary products business and will now include additional brands from DPP. The company has offices in Australia, Europe, Latin America and North America. DPx Holdings was founded in March 2014 and is headquartered in Framingham, MA. | - |
Susan Alexander | F | 67 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 21 years |
Gilmore O’Neill | M | 59 | 18 years | |
Michel Lagarde | M | 50 | 8 years | |
Stelios Papadopoulos | M | 75 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 16 years |
Michael J. Lehmann | M | 61 |
DPx Holdings BV
DPx Holdings BV Drugstore ChainsRetail Trade DPx Holdings BV provides pharmaceutical services, fine chemicals and proprietary products and technologies. It operates business through three business unites which include Patheon, DSM Fine Chemicals and Banner Life Sciences. Patheon consists of pharmaceutical services, which include commercial manufacturing capabilities, pharmaceutical development services, as well as the biologics and biosolutions businesses; DSM Fine Chemicals includes active pharmaceutical ingredients services as well as the ES/IM business offer is primarily comprised of agricultural and crop protection chemicals and specialty intermediates; and Banner Life Sciences serves the needs of the proprietary products business and will now include additional brands from DPP. The company has offices in Australia, Europe, Latin America and North America. DPx Holdings was founded in March 2014 and is headquartered in Framingham, MA. | 6 years |
Emma Reeve | F | 63 | 3 years | |
Caroline Dorsa | F | 64 | 14 years | |
Harry Gill | M | 63 |
DPx Holdings BV
DPx Holdings BV Drugstore ChainsRetail Trade DPx Holdings BV provides pharmaceutical services, fine chemicals and proprietary products and technologies. It operates business through three business unites which include Patheon, DSM Fine Chemicals and Banner Life Sciences. Patheon consists of pharmaceutical services, which include commercial manufacturing capabilities, pharmaceutical development services, as well as the biologics and biosolutions businesses; DSM Fine Chemicals includes active pharmaceutical ingredients services as well as the ES/IM business offer is primarily comprised of agricultural and crop protection chemicals and specialty intermediates; and Banner Life Sciences serves the needs of the proprietary products business and will now include additional brands from DPP. The company has offices in Australia, Europe, Latin America and North America. DPx Holdings was founded in March 2014 and is headquartered in Framingham, MA. | 10 years |
Eric Benjamin | M | 41 | 6 years | |
R. Keith | F | 56 | 4 years | |
Dion Weisler | M | 56 | 7 years | |
Elliott Levy | M | 65 | 1 years | |
David Scadden | M | 71 | 5 years | |
Michael Boxer | M | 62 | 6 years | |
Stephen Williamson | M | 57 | 23 years | |
Anthony Smith | M | 62 | - | |
Stephen Sherwin | M | 75 | 14 years | |
Daniel Agroskin | M | 47 |
DPx Holdings BV
DPx Holdings BV Drugstore ChainsRetail Trade DPx Holdings BV provides pharmaceutical services, fine chemicals and proprietary products and technologies. It operates business through three business unites which include Patheon, DSM Fine Chemicals and Banner Life Sciences. Patheon consists of pharmaceutical services, which include commercial manufacturing capabilities, pharmaceutical development services, as well as the biologics and biosolutions businesses; DSM Fine Chemicals includes active pharmaceutical ingredients services as well as the ES/IM business offer is primarily comprised of agricultural and crop protection chemicals and specialty intermediates; and Banner Life Sciences serves the needs of the proprietary products business and will now include additional brands from DPP. The company has offices in Australia, Europe, Latin America and North America. DPx Holdings was founded in March 2014 and is headquartered in Framingham, MA. | 9 years |
Daniel P. Shine | M | - | 26 years | |
Michael Minogue | M | 57 | 7 years | |
Bernadette Connaughton | F | 65 | 3 years | |
Meeta Chatterjee | M | 69 | 4 years | |
Robert Perez | M | 59 |
Biomedical Sciences Careers Program, Inc.
| 23 years |
Nelson Chai | M | 58 | 14 years | |
C. Harris | M | 67 | 12 years | |
Scott Sperling | M | 66 | 18 years | |
Joseph Holmes | M | 45 | 7 years | |
George Scangos | M | 76 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016.
Biomedical Sciences Careers Program, Inc.
| 8 years |
Debora Spar | M | 60 | 5 years | |
Ruby Chandy | F | 62 | 2 years | |
Eric Rowinsky | M | 67 | 14 years | |
Karen Nelson | M | - | - | |
Kate X. Zhang | M | - | 6 years | |
Mei Baisong | M | 60 | 2 years | |
Chi Li | M | - | 3 years | |
Gianluca Pettiti | M | 45 | 18 years | |
Mike Shafer | M | - | 15 years | |
Rafael Tejada | M | - | 9 years | |
Michael Dambach | M | 57 | 17 years | |
John Brian Sabo | M | 54 | - | |
Garret Hampton | M | 58 | - | |
Sara Nochur | M | 63 |
Biomedical Sciences Careers Program, Inc.
| - |
Tyler Jacks | M | 63 | 15 years | |
Lisa Britt | F | 56 | 7 years | |
Andrew P. Slifka | M | 55 |
The Rivers School Corp.
| - |
Corinne Broderick | F | - |
Biomedical Sciences Careers Program, Inc.
| - |
Alan Sachs | M | - | 8 years | |
Daniel Revers | M | 61 |
The Rivers School Corp.
| - |
Bob J. Davis | M | 67 |
The Rivers School Corp.
| - |
Erick Lucera | M | 57 | 1 years | |
Julia Chen | F | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
William Young | M | 79 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB)
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 17 years |
Craig Eric Schneier | M | 76 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 8 years |
Robert W. Pangia | M | 72 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 24 years |
William Rastetter | M | 75 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 19 years |
Hans-Peter Hasler | M | 68 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 10 years |
Patrick Sullivan | M | 72 | 5 years | |
Cecil B. Pickett | M | 78 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016.
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 3 years |
Paul Levy | M | 76 | 9 years | |
Jim Manzi | M | 72 | 23 years | |
Alphonse Galdes | M | 71 | - | |
Doaa A. Fathallah | F | - | 6 years | |
Paul Clancy | M | 62 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 16 years |
Kevin Bitterman | M | 47 | 5 years | |
Robert A. Hamm | M | 72 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 7 years |
Katrine Bosley | F | 56 | 5 years | |
Peter Kellogg | M | 67 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB)
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 7 years |
Jim Post | M | - | 5 years | |
Michael Lytton | M | 67 | 5 years | |
Connie Matsui | F | 70 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016.
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 18 years |
Lynn Schenk | F | 79 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 25 years |
James Tobin | M | 79 | 5 years | |
Cynthia Collins | F | 65 | 3 years | |
Dean Frederick Wilson | M | - | 6 years | |
Joseph Mara | M | 49 | - | |
Alex Bruni | M | - |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA. | 1 years |
Shiraz Ladiwala | M | 58 | 24 years | |
Lynne Sullivan | F | 58 | 10 years | |
Samantha Truex | F | - | 8 years | |
Mark Shearman | M | 62 | - | |
Boris Nikolic | M | 54 | 3 years | |
Jennifer Almond | F | - | - | |
Timothy D. Hunt | M | - | 14 years | |
Nancy L. Leaming | F | 76 | 14 years | |
Peter Thomas Bigelow | M | - | 1 years | |
Alexander Denner | M | 54 | 14 years | |
Paul M. Garofolo | M | 53 | 6 years | |
Jeffrey P. McMullen | M | 72 | - | |
Michael MacLean | M | 58 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 4 years |
Eric S. Hoffman | M | 54 | 5 years | |
Geoffrey Glass | M | 50 | 5 years | |
Regina Sommer | F | 66 | 9 years | |
Alexis Borisy | M | 52 | 5 years | |
James L. Vincent | M | 84 | 12 years | |
Ramsey A. Frank | M | 63 | 5 years | |
Joaquín Bautista Viso | M | 81 | 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 90 | 90.00% |
Canada | 13 | 13.00% |
Netherlands | 12 | 12.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- James Mullen
- Personal Network